Evidence map›Paper›PMID 31373576›Full record

ArticleActa crystallographica. Section D, Structural biology2019

Structure determination of the CAMP factor of Streptococcus agalactiae with the aid of an MBP tag and insights into membrane-surface attachment.

Yajuan Li, Weihong Zeng, Yuelong Li, Weirong Fan, Huan Ma, Xiaojiao Fan, Jiansheng Jiang, Eric Brefo-Mensah, Yuzhu Zhang, Meixiang Yang and 3 more

Open access · greenAbstract read
In one paragraph

Article in Acta crystallographica. Section D, Structural biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 13 citations in OpenAlex.

  1. Integrated Evaluation ofInternational journal of molecular sciences · 2026
    Article
  2. Review
  3. Article
  4. PCR targeting 16S rRNA,Biomarkers in medicine · 2025
    Article
  5. Biology · 2024
    Review
  6. Frontiers in bioengineering and biotechnology · 2022
    Review
  7. Article
  8. Article
  9. Research Advances on Tilapia Streptococcosis.Pathogens (Basel, Switzerland) · 2021
    Review
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 3 countries.

Yajuan LiDivision of Molecular Medicine, Hefei National Laboratory for Physical Sciences at Microscale, CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Life Sciences, University of Science and Technology of China, Hefei 230027, People's Republic of China.
Weihong ZengDivision of Molecular Medicine, Hefei National Laboratory for Physical Sciences at Microscale, CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Life Sciences, University of Science and Technology of China, Hefei 230027, People's Republic of China.ORCID 0000-0003-3853-3630
Yuelong LiDivision of Molecular Medicine, Hefei National Laboratory for Physical Sciences at Microscale, CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Life Sciences, University of Science and Technology of China, Hefei 230027, People's Republic of China.
Weirong FanShanghai Jiao Tong University Affiliated Sixth People's Hospital South Campus, Shanghai, People's Republic of China.
Huan MaDivision of Molecular Medicine, Hefei National Laboratory for Physical Sciences at Microscale, CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Life Sciences, University of Science and Technology of China, Hefei 230027, People's Republic of China.
Xiaojiao FanDivision of Molecular Medicine, Hefei National Laboratory for Physical Sciences at Microscale, CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Life Sciences, University of Science and Technology of China, Hefei 230027, People's Republic of China.
Jiansheng JiangLaboratory of Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20914, USA.ORCID 0000-0003-0964-5481
Eric Brefo-MensahDepartment of Chemistry, University of Waterloo, Waterloo, ON N2L 3G1, Canada.
Yuzhu ZhangProcessed Foods Research Unit, USDA-ARS, Western Regional Research Center, Albany, CA 94710, USA.ORCID 0000-0001-7882-5692
Meixiang YangThe First Affiliated Hospital, Biomedical Translational Research Institute and School of Pharmacy, Jinan University, Guangzhou 510632, People's Republic of China.
Zhongjun DongInstitute for Immunology and School of Medicine, Tsinghua University, Beijing 100086, People's Republic of China.
Michael PalmerDepartment of Chemistry, University of Waterloo, Waterloo, ON N2L 3G1, Canada.
Tengchuan JinDivision of Molecular Medicine, Hefei National Laboratory for Physical Sciences at Microscale, CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Life Sciences, University of Science and Technology of China, Hefei 230027, People's Republic of China.ORCID 0000-0002-1395-188X
University of Science and Technology of China · CNUniversity of Waterloo · CAJinan University · CNNational Institutes of Health · USShanghai Jiao Tong University · CNTsinghua University · CNWestern Regional Research Center · US

Funding

Chinese Academy of Sciences XDB29030104Fundamental Research Funds for the Central Universities WK2070000097Fundamental Research Funds for the Central Universities WK2070000108National Natural Science Foundation of China, Major Research Plan U1732109National Natural Science Foundation of China, Young Scientists Fund 31600598National Natural Science Foundation of China, Young Scientists Fund 31870731
6 · The paper itself

Abstract

CAMP factor is a unique α-helical bacterial toxin that is known for its co-hemolytic activity in combination with staphylococcal sphingomyelinase. It was first discovered in the human pathogen Streptococcus agalactiae (also known as group B streptococcus), but homologous genes have been found in many other Gram-positive pathogens. In this study, the efforts that led to the determination of the first structure of a CAMP-family toxin are reported. Initially, it was possible to produce crystals of the native protein which diffracted to near 2.45 Å resolution. However, a series of technical obstacles were encountered on the way to structure determination. Over a period of more than five years, many methods, including selenomethionine labeling, mutations, crystallization chaperones and heavy-atom soaking, were attempted, but these attempts resulted in limited progress. The structure was finally solved using a combination of iodine soaking and molecular replacement using the crystallization chaperone maltose-binding protein (MBP) as a search model. Analysis of native and MBP-tagged CAMP-factor structures identified a conserved interaction interface in the C-terminal domain (CTD). The positively charged surface may be critical for binding to acidic ligands. Furthermore, mutations on the interaction interface at the CTD completely abolished its co-hemolytic activities. This study provides novel insights into the mechanism of the membrane-permeabilizing activity of CAMP factor.

Indexed as

Streptococcus agalactiaeBacterial ProteinsCrystallography, X-RayHemolysin ProteinsMaltose-Binding ProteinsMutationProtein BindingProtein DomainsRecombinant Fusion ProteinsBacterial ProteinsCAMP protein, StreptococcusHemolysin ProteinsMaltose-Binding ProteinsRecombinant Fusion ProteinsCAMP factorgroup B streptococcushemolytic mechanismMBP tagStreptococcus agalactiaestructure determination

Identifiers

PMID31373576
PMCPMC8493612
OpenAlexW2966353563

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.